TITLE:
Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia

CONDITION:
Schizophrenia

INTERVENTION:
Aripiprazole

SUMMARY:

      A study to evaluate three doses of aripiprazole versus placebo in patients with an acute
      episode of schizophrenia
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Men and women, ages 18 and older, with a worsening of schizophrenia symptoms over the
             past three months
      
